DIANA DALE: Open Payments
NPI 1407887037 · ROCKY RIVER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 34 payments from 13 companies in 2025. Trend: 2023 $571 · 2024 $728 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| Lundbeck LLC | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Janssen Pharmaceuticals, Inc | 3 | $76 |
| ABBVIE INC. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| Alkermes, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $41 |
Products named: REXULTI, HETLIOZ, CAPLYTA, SPRAVATO, VRAYLAR, TRINTELLIX, INGREZZA, Qelbree.
Industry payments across OH — which companies pay providers there.
